Results 171 to 180 of about 926 (182)

Does Saroglitazar make a difference in MASLD management?

Journal of Clinical and Experimental Hepatology
Geeta Desai, Santosh Hajare
openaire   +1 more source

Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models

Liver International, 2018
Mukul R Jain, Walter Wahli
exaly  

SAROGLITAZAR: A NEW CARDIOMETABOLIC TREATMENT FOR DIABETIC DYSLIPIDEMIA

International Journal of Research Publication and Reviews
Akanksha S. Lahoti, Smita J. kurkute, Asso.Prof. Sachin D. Wakchaure   +2 more
openaire   +1 more source

Saroglitazar Magnesium in the Treatment of Non-Alcoholic Steatohepatitis

Case Medical Research, 2019
openaire   +1 more source

Virtual identification of novel PPARα/γ dual agonists by scaffold hopping of saroglitazar

Journal of Biomolecular Structure and Dynamics, 2018
Wen-Qing Jia, Zhi Jing, Shu-Qing Wang
exaly  

Quantitative determination of saroglitazar, a predominantly PPAR alpha agonist, in human plasma by a LC–MS/MS method utilizing electrospray ionization in a positive mode

Biomedical Chromatography, 2016
Kevinkumar Kansagra, Nuggehally R Srinivas   +1 more
exaly  

Limited Sampling Strategy for Accurate Prediction of Pharmacokinetics of Saroglitazar: A 3-point Linear Regression Model Development and Successful Prediction of Human Exposure

Clinical Therapeutics, 2018
Nuggehally R Srinivas, Deven V Parmar
exaly  

Abstract #1233: 9-Month Safety and Efficacy of Saroglitazar in Diabetic Dyslipidemia

Endocrine Practice, 2015
Shashank Joshi, Jothydev Kesavadev, Sudhir Bhandari, Banshi Saboo, Ashok Jaiswal, Pankaj Patel   +5 more
openaire   +1 more source

A Multicenter, Prospective, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared to Pioglitazone 45 mg in Diabetic Dyslipidemia (PRESS V)

Journal of Diabetes Science and Technology, 2014
Satinath Mukhopadhyay, Anil Bhansali, Rajendrakumar H Jani   +2 more
exaly  

Effectiveness of Saroglitazar in MASLD-An open label real world study

Journal of Clinical and Experimental Hepatology
Abhinav Agarwal, Manoj Kumar Agarwal
openaire   +1 more source